BioCryst Pharmaceuticals Reaches Analyst Target Price

In recent trading, shares of BioCryst Pharmaceuticals Inc (Symbol: BCRX) have crossed above the average analyst 12-month target price of $10.62, changing hands for $11.85/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downIn recent trading, shares of BioCryst Pharmaceuticals Inc (Symbol: BCRX) have crossed above the average analyst 12-month target price of $10.62, changing hands for $11.85/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downRead MoreMarkets,Stocks,ETFsStocks Feed